Zoryve 0.3 % (Roflumilast CREAM) 0.3 %

Zoryve 0.3% cream is a topical medication used to manage inflammatory skin conditions. It is primarily indicated for the following conditions:

• Plaque psoriasis: Reduces inflammation and symptoms associated with plaque psoriasis in adults and children 12 years of age and older.
• Seborrheic dermatitis: Helps manage symptoms of seborrheic dermatitis in individuals 9 years of age and older.
• Atopic dermatitis (eczema): Treats mild to moderate atopic dermatitis in patients 6 years of age and older.

• Roflumilast, the active ingredient in Zoryve 0.3% cream, works by selectively inhibiting phosphodiesterase-4 (PDE4). This inhibition leads to increased levels of cyclic adenosine monophosphate (cAMP) within cells, which reduces the production of inflammatory cytokines. By targeting this pathway, roflumilast helps to decrease inflammation and improve symptoms associated with various skin conditions.

Zoryve 0.3% cream may cause several side effects, ranging from common to serious or rare. Common Side Effects:

• Headache: A frequent side effect reported by users of the cream.
• Diarrhea: Some patients may experience gastrointestinal discomfort.
• Nausea: Mild to moderate nausea can occur.
• Trouble sleeping: Difficulty sleeping has been reported by some users.
• Application site pain: Discomfort or pain at the site of application is possible.
• Upper respiratory tract infections: Some users may experience cold-like symptoms.
• Urinary tract infections (UTIs): Infections of the urinary tract have been reported.

Serious or Rare Side Effects

• Bladder pain: Pain in the bladder area may occur.
• Bloody or cloudy urine: Indicative of a potential urinary tract infection.
• Difficult, burning, or painful urination: May signal a more serious infection.
• Frequent urge to urinate: Could be a sign of a urinary tract issue.

Zoryve 0.3% cream should be used with caution and under the guidance of a healthcare provider. Important precautions include:

• Liver function: Patients with decreased liver function should discuss the use of this medication with their doctor, as it may build up in the body and cause side effects.
• Allergies: Inform your healthcare provider if you are allergic to roflumilast or any of the ingredients in the cream.
• Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. Consult your doctor immediately if you become pregnant while using this medication.
• Children: The safety and effectiveness of this medication for plaque psoriasis have not been established for children under 12 years of age. For seborrheic dermatitis, it is not recommended for children under 9 years of age, and for atopic dermatitis, it is not recommended for children under 6 years of age.
• Application: Do not use Zoryve in or on your eyes, mouth, or vagina. Avoid contact with these areas.
• Store at room temperature: Protect the medication from light and moisture, and keep it out of the reach of children.

Zoryve 0.3% cream may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid):

• Moderate to severe liver impairment: Patients with moderate to severe liver impairment should not use Zoryve cream.
• Allergy to roflumilast: Avoid using the medication if you are allergic to roflumilast or any of its ingredients.

Moderate Interactions (Monitor Closely)

• Other topical medications: Inform your healthcare provider about all topical medications you are using to avoid potential interactions.
• Systemic medications: Discuss all systemic medications you are taking with your healthcare provider to ensure safe use of Zoryve cream.
• Pregnancy and breastfeeding: Consult your healthcare provider before using this medication if you are pregnant or breastfeeding.